{"category":{"kind":"industry","slug":"crispr","name":"CRISPR","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-03T06:19:07.483Z","updated_at":"2026-09-03T06:19:07.483Z","example":false,"profile_url":"/industries/crispr","is_stub":true,"member_count":4,"member_counts":{"company":4}},"members":[{"listing_type":"company","name":"Uncommon Therapeutics","slug":"uncommon-therapeutics","tagline":"A Disease Focused Biotech, Building Multiple Billion Dollar Drugs","description":"Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.\n\nUncommon Therapeutics is a Y Combinator company (Winter 2025). YC-listed status: Active.","url":"https://www.uncommontherapeutics.com/","is_stealth":false,"normalized_domain":"uncommontherapeutics.com","normalized_url_key":"uncommontherapeutics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/791a2a1e71f62bafa47311d3711d9cab4712eea4.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/uncommon-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","CRISPR","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:54:06.858Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2025","Gene Therapy","CRISPR","Biotechnology"],"one_liner_for_search":"Uncommon Therapeutics — A Disease Focused Biotech, Building Multiple Billion Dollar Drugs (Y Combinator Winter 2025)","canonical_facts":["Y Combinator batch: Winter 2025","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:54:06.858Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/industries/crispr"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:54:06.858Z","updated_at":"2026-09-03T07:54:06.858Z"}},{"listing_type":"company","name":"Nephrogen","slug":"nephrogen","tagline":"Curative genetic medicines for kidney diseases","description":"Nephrogen is a Stanford biotech spin-out developing curative genetic medicines for kidney and pancreatic diseases. Kidney disease alone affects 1 in 7 Americans, and neither indication has any approved gene-based therapies. \n\nNephrogen's underlying platform combines AI and high-throughput screening to engineer safer, more efficient, and less expensive gene delivery vehicles for reaching the kidney and pancreas, and has attracted non-dilutive funding from seven major pharmaceutical companies including Merck KGaA, Novartis, and Bristol Myers Squibb.\n\nNephrogen is a Y Combinator company (Summer 2020). YC-listed status: Active.","url":"https://www.nephrogenbiotech.com/","is_stealth":false,"normalized_domain":"nephrogenbiotech.com","normalized_url_key":"nephrogenbiotech.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/ce4f8b04c9fefa06f0088d04f45b91af1e3fe8aa.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/nephrogen","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","CRISPR","Biotech"],"stage":null,"founded_year":null,"location":"New York City, NY, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:35:29.787Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2020","Gene Therapy","CRISPR","Biotech"],"one_liner_for_search":"Nephrogen — Curative genetic medicines for kidney diseases (Y Combinator Summer 2020)","canonical_facts":["Y Combinator batch: Summer 2020","YC company status: Active","Team size (per YC directory): 5","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:35:29.787Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/industries/crispr"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:35:29.787Z","updated_at":"2026-09-03T06:35:29.787Z"}},{"listing_type":"company","name":"Algen Biotechnologies","slug":"algen-biotechnologies","tagline":"Using CRISPR to find treatments for cancer and inflammation","description":"Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.\n\nAlgen Biotechnologies is a Y Combinator company (Winter 2020). YC-listed status: Active.","url":"https://www.algenbio.com/","is_stealth":false,"normalized_domain":"algenbio.com","normalized_url_key":"algenbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/41218b0dee65a988940509b3fe258626c5137590.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/algen-biotechnologies","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.algenbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.algenbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","CRISPR","Biotech","Therapeutics","Drug discovery","AI"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:32:33.310Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2020","CRISPR","Biotech","Therapeutics","Drug discovery","AI"],"one_liner_for_search":"Algen Biotechnologies — Using CRISPR to find treatments for cancer and inflammation (Y Combinator Winter 2020)","canonical_facts":["Y Combinator batch: Winter 2020","YC company status: Active","Team size (per YC directory): 15","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Algen Biotechnologies, Inc.","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:32:33.310Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/industries/crispr"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:32:33.310Z","updated_at":"2026-09-03T06:32:33.310Z"}},{"listing_type":"company","name":"LEAH Labs","slug":"leah-labs","tagline":"Living therapies for pets first, and their people next","description":"LEAH Labs is building living therapies for pets first, and their people next. We're first focused on CAR-T cell therapy for dogs with B cell lymphoma, the naturally occurring clinical analog of human non-Hodgkin's lymphoma. CAR-T cells are curative in humans, and our early results are showing the same - we're inducing remissions in pets with late stage lymphomas. Our virus-free gene editing platform allows us to engineer a dose of CAR-T cell therapy for ~$500, and brings the promise of a curative outcome. Given our safety and efficacy data to date, we believe this product could be used by general practice veterinarians, meaning we have thousands of customers all across the USA who typically treat with palliative care or refer cancer patients to specialty oncologists. Our CAR-T cell platform is regulated by the USDA, not the FDA, affording us a cost effective \"full stack\" to iterate and innovate on CAR-T cell therapy from a hypothesis through clinical validation.\n\nLEAH Labs is a Y Combinator company (Winter 2019). YC-listed status: Active.","url":"https://leahlabs.com/","is_stealth":false,"normalized_domain":"leahlabs.com","normalized_url_key":"leahlabs.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/6907f0370b96042be3d0036ddc25c34015a02b50.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/leah-labs","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://leahlabs.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://leahlabs.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","CRISPR","Cell Therapy","Drug discovery"],"stage":null,"founded_year":null,"location":"Minneapolis, MN, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:19:07.483Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2019","CRISPR","Cell Therapy","Drug discovery"],"one_liner_for_search":"LEAH Labs — Living therapies for pets first, and their people next (Y Combinator Winter 2019)","canonical_facts":["Y Combinator batch: Winter 2019","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Lifengine Animal Health Laboratories, Incorporated","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:19:07.483Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/industries/crispr"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:19:07.483Z","updated_at":"2026-09-03T06:19:07.483Z"}}],"total":4,"limit":50,"offset":0}